Plasma disappearance of substances taken up largely by the liver, such as bromosul-fophthalein (BSP) (1-3) or indocyanine green (4, 5), has been used widely as a test for liver function. Recently, the plasma disappearance of a bile acid, cholylglycine, has been proposed as a test for hepatic injury (6, 7). This bile acid clearance is based on the assumption that the plasma disappearance of cholylglycine may be equated with hepatic uptake. To test this assumption, we have defined the tissue distribution of intravenously injected cholylglycine in rats and hamsters; we have used animals with an acute bile fistula, as well as animals with a bile duct obstruction.
Chemicals. [1-14C]Cholylglycine (sp act 51.7 mCi/mmole) was purchased from Amersham/Searle (Arlington Heights, 111.) and had a radiopurity greater than 96% by zonal scanning (9) using a thin-layer system for bile acid conjugates (10). [99Tc]Albumin was prepared using a commercial kit (New England Nuclear Radiopharmaceutical Division, North Billerica, Mass.). A solution of [l-14C]cholylglycine was mixed with [99Tcjalbumin to give a concentration of 5 μCi of I4C and 15 μCi of 99Tc radioactivity per milliliter.